Skip to content

Cervical spondylotic myelopathy: Application of spinal diffusion-based microstructural imaging (DMI) and phase-contrast MRI

Cervical spondylotic myelopathy: Application of spinal diffusion-based microstructural imaging (DMI) and phase-contrast MRI - MIDICAM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012962
Enrollment
150
Registered
2018-01-17
Start date
2018-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M47.12 G99.2

Interventions

Group 1: In this propective study we will apply additional new MRI examinations (MDI/PC-MRI) in patients with cervical spondylotic pathologies and possible associated myelopathy to figure out their di

Sponsors

Klinik für Neurochirurgie, Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a) Symptoms of a radiculopathy od myelopthy induced by cervical degerative disease in combination with a disk herniation or cervical stenosis with contact to the cervical myelon at the MR imaging. b) Age > 18 years c) Informed consent.

Exclusion criteria

Exclusion criteria: a) MRI exclusion criteria b) Patients with prior cervical operations c) Non-degenerative causes for the pathological changings of the cervical spine (tumor, infection/inflammation, tramatic injuries) d) severe internistic pathologies e) severe neurologic or psychiatric diseases, e.g. dementia, Parkinson's disease, Multiple sclerosis, CNS inflammation, Depression, Schizophrenia

Design outcomes

Primary

MeasureTime frame
Sensitivity and specifity of the MIDI concerning functional (clinical or electrophysiological) or abstinent myelopathy.

Secondary

MeasureTime frame
Pathologic changings in the MIDI compared to conventional MRI diagnostics in cervical myelopathy patients. Development of clinical, electrophysiological and conventional MRI changings in initial pathological altered MIDI.

Countries

Germany

Contacts

Public ContactMarc Hohenhaus

Klinik für Neurochirurgie, Universitätsklinikum Freiburg

marc.hohenhaus@uniklinik-freiburg.de076127050010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 1, 2026